C. Blondeau

发表

An Analytical Model Applied to a Multicenter Pneumococcal Enzyme-Linked Immunosorbent Assay Study

I. Jónsdóttir, B. Plikaytis, D. Goldblatt, 2000, Journal of Clinical Microbiology.

Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.

J. Lang, J. Zuckerman, J. Zuckerman, 1999, The American journal of tropical medicine and hygiene.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

I. Jónsdóttir, B. Plikaytis, D. Goldblatt, 2000, Journal of clinical microbiology.

Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccines.

P. Coursaget, P. Saliou, B. Fritzell, 1995, Vaccine.

Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age.

M. Granström, B. Claesson, A. Hoffenbach, 1998, The Pediatric infectious disease journal.

New acellular pertussis-containing paediatric combined vaccines.

H. Salomón, S. Wood, A. Hoffenbach, 1999, Vaccine.

Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation.

A. Finn, C. Thornton, F. Bell, 1996, Archives of disease in childhood.

Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: A 7-year follow up

P. Saliou, T. Swartz, M. Fletcher, 2002, European Journal of Epidemiology.

Combined diphtheria, tetanus,pertussis, and Haemophilus influenzae typebvaccines forprimary

A. Finn, Alex Martín, C. Blondeau, 1996 .

Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.

M. Levine, K. Kotloff, R. Lagos, 1998, The Pediatric infectious disease journal.

IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects.

J. Excler, E. Dulioust, D. Salmon-Céron, 2000, AIDS research and human retroviruses.

Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.

J. Excler, E. Dulioust, D. Salmon-Céron, 1999, AIDS research and human retroviruses.

Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients.

J. Excler, E. Dulioust, D. Salmon-Céron, 1999, Journal of immunological methods.

Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy.

J. Lang, R. Jaussaud, A. Strady, 1998, The Journal of infectious diseases.

Adjuvants for influenza vaccine

B. Fanget, J. Ronco, A. Françon, 1998 .

False-positive human immunodeficiency virus screening test related to rabies vaccination.

S. Plotkin, E. Loupi, C. Blondeau, 1995, Archives of pathology & laboratory medicine.

Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization.

K. Keddy, K. Klugman, C. Blondeau, 1999, Vaccine.

The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella

R. Pebody, N. Andrews, A. Tischer, 2000, Epidemiology and Infection.

[Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine].

J. Roux, J. Boutin, J. Excler, 1996, Sante.

Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection

B. Autran, J. Tartaglia, P. Chong, 1999 .

Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine.

B. Yvonnet, P. Coursaget, J. Chiron, 1992, Vaccine.

Haemophilus influenzae type B (Hib) antibody responses in children given diphtheria-tetanus-acellular pertussis-Hib combination vaccines.

A. Finn, F. Bell, C. Blondeau, 2000, The Journal of infectious diseases.

Immunogenicity of a hexavalent combination vaccine in rhesus monkeys.

J. Smith, M. Caulfield, S. Lentsch, 2000, Vaccine.

Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.

A. Goudeau, C. Xueref, P. Brasseur, 1996, Biologicals (Print).

Safety and immunogenicity of a new equine tetanus immunoglobulin associated with tetanus-diphtheria vaccine.

J. Lang, R. Forrat, C. Lutsch, 2000, The American journal of tropical medicine and hygiene.

The seroepidemiology of measles in Western Europe

France, Finland., J. Schellekens, 2001, Epidemiology and Infection.